Solifenacin

Category: pharmacological

Aliases: VESIcare

Pharmacological Mechanism

Competitive muscarinic receptor antagonist (M3-preferring) for overactive bladder — reduces detrusor overactivity. Hepatic CYP3A4 metabolism.

Half-Life (t½)

PO: 55h

Dosing Guidelines

• PO: Typical 5mg (Range: 5 - 10 mg)

Target Organ Systems

• nervous